Nephron Protection in Diabetic Kidney Disease

N Engl J Med. 2016 Nov 24;375(21):2096-2098. doi: 10.1056/NEJMcibr1608564.

Authors

Hans-Joachim Anders¹, John M Davis¹, Klaus Thurau¹

Affiliation

¹ From Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität München (H.-J.A.), and the Department of Physiology, Ludwig-Maximilians-Universität München (J.M.D., K.T.) - both in Munich, Germany.

PMID: 27959742
DOI: 10.1056/NEJMcibr1608564

No abstract available

MeSH terms

Benzhydryl Compounds / therapeutic use
Diabetic Nephropathies / drug therapy*
Diabetic Nephropathies / physiopathology
Glomerular Filtration Rate
Glucosides / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use
Nephrons / drug effects
Nephrons / physiopathology*
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Benzhydryl Compounds
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
empagliflozin